Design and discovery of tyrosinase inhibitors based on a coumarin scaffold. Issue 114 (3rd November 2015)

• Record Type: Journal Article
• Authors: Matos, M. J.; Varela, C.; Vilar, S.; Hripcsak, G.; Borges, F.; Santana, L.; Uriarte, E.; Fais, A.; Di Petrillo, A.; Pintus, F.; Era, B.
• Is Part Of: RSC advances. Volume 5:Issue 114(2015)
• Page Start: 94227
• Page End: 94235
• Publication Date: 2015-11-03
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/c5ra14465e
• Languages: English
• ISSNs: 2046-2069

Abstract

Abstract : A novel series of 3-aryl and 3-heteroarylcoumarins displaying tyrosinase inhibitory activity. Abstract : In this manuscript we report the synthesis, pharmacological evaluation and docking studies of a selected series of 3-aryl and 3-heteroarylcoumarins with the aim of finding structural features for the tyrosinase inhibitory activity. The synthesized compounds were evaluated as mushroom tyrosinase inhibitors. Compound12b showed the lowest IC50 (0.19 μM) of the series, being approximately 100 times more active than kojic acid, used as a reference compound. The kinetic studies of tyrosinase inhibition revealed that12b acts as a competitive inhibitor of mushroom tyrosinase withl -DOPA as the substrate. Furthermore, the absence of cytotoxicity in B16F10 melanoma cells was determined for this compound. The antioxidant profile of all the derivatives was evaluated by measuring radical scavenging capacity (ABTS and DPPH assays). Docking experiments were carried out on mushroom tyrosinase structures to better understand the structure–activity relationships.